相关实验视频

Updated: Jun 17, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

从先前的慢性髓性恶性瘤的演变不会影响NPM1-突变AML的生存结果

Elliot Smith¹, Eshetu G Atenafu², Aniket Bankar¹

¹Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

European journal of haematology

|August 8, 2024

概括

急性髓性白血病 (AML) 中的核胺-1 (NPM1) 突变不会使预后恶化,即使AML是从先前的慢性髓性恶性瘤中演变出来的. 这一发现支持NPM1作为一个关键的AML定义突变.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

核胺-1 (NPM1) 突变定义了急性骨髓性白血病 (AML) 的亚型,预后通常有利.
在慢性骨髓性恶性瘤 (二次性AML或sAML) 后发展的AML中NPM1突变的预后影响仍然不确定.

研究的目的:

为了调查NPM1突变在AML患者的预后意义,从先前的慢性骨髓性恶性瘤演变.
为了比较NPM1-突变的de novoAML与NPM1-突变的sAML的结果.

主要方法:

对NPM1-突变新型AML和sAML患者的回顾性图表审查.
sAML被定义为AML之前有一个慢性阶段的骨髓性恶性瘤.
分析了生存结果,包括无白血病生存率 (LFS) 和整体生存率 (OS).

主要成果:

在575名NPM1突变患者中,51名 (8.9%) 患有sAML.
从慢性骨髓性恶性瘤发展为sAML的中位时间为3.6个月.
在 de novo 和 sAML 组之间没有观察到两年LFS (52.0% vs. 51.2%) 或 OS (56.3% vs. 49.4%) 的显著差异.

结论:

在NPM1突变的背景下,AML从先前的骨髓性恶性瘤的演变似乎不是预后不佳的重要预测因素.
在大多数sAML病例中进展的时间相对较短,加强了NPM1作为AML定义突变的重要性.

关键词:

在 MDS MDS 中.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.二级AML是指第二级AML.

更多相关视频

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

相关概念视频

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...